Schwartz Jeffrey Lawrence's Form 4 filing
Kestra Medical Technologies, Ltd. (KMTS) · filed Sep 10, 2026
- Accession no.
- 0000950130-26-000223
- Filed
- Sep 10, 2026, 8:43 PM ET
- Trade date
- Sep 8-9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $97.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwartz Jeffrey LawrenceCIK 0001702957 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Shares | SSaleDisposed | −3,890 | $25.18 | −$97,942.42 | 7,019 | Direct | |
| Sep 9, 2026 | Common Shares | AGrant or awardAcquired | +7,217 | – | – | 14,236 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.